Agreed. Actually right now the Marijuana path is hurting the stock more than helping it in my opinion. When they get it up and running, with proven Marijuana earnings, that won't be the case, but for now, they are an importer not a weed ticker, but everyone is looking at it like a Marijuana ticker, where they are currently not yet a player, and ignoring the profitable business they do have that actually funds the Marijuana path, and gives them a leg up in the future when the other companies' fund raising (read as revenue from Dilution if you prefer) is consumed.
